Device created to deliver immunotherapy without side effects: Single direct-to-tumor drug-delivery device offers hope for treating triple-negative breast cancer

Scientists have developed a nanodevice to deliver immunotherapy without side effects to treat triple-negative breast cancer. Inserted straight into a tumor, this device makes it possible to deliver a one-time, sustained-release dose that would eliminate the need for patients to undergo several IV treatments over time.